|Previous Section||Index||Home Page|
19 Sept 2002 : Column 342Wcontinued
The number of deaths from asthma is gradually declining. The Department's hospital episode statistics show in-hospital deaths, where the patient's main diagnosis was asthma, falling from 301 in 199899 to 213 in 200001.
The Office for National Statistics report that the international classification of disease, ICD9 493 (Asthma) recorded for England and Wales that in 1998 there were 1,366 deaths caused by asthma and by 2000 that had fallen to 1,272 deaths.
Dr. Kumar: To ask the Secretary of State for Health what recent discussions he has had with the Medical Research Council to give further priority to research into asthma; and if he will make a statement. 
19 Sept 2002 : Column 343W
Jacqui Smith [holding answer 23 July 2002]: Asthma is a priority area for the Medical Research Council (MRC) and it supports a wide range of research projects looking at asthma ranging from basic research to applied clinical studies. The MRC spend in the area in 200001 was approximately £3 million. Under the terms of the Concordat, the Health Departments will be meeting with the MRC later this year. Respiratory disease will be a major item for discussion at this meeting.
Ms Atherton: To ask the Secretary of State for Health (1) whether he plans to address the information and support needs of bereaved families affected by SUDEP and other epilepsy deaths following the evidence of the National Sentinel Audit of Epilepsy-Related Death; 
(3) whether steps are being taken to set a national target for reduction of epilepsy deaths; 
(4) if implementation of the action plan addressing findings of the National Audit of Epilepsy-Related Death will include specific action by primary care trusts; 
(5) what steps his Department is taking to promote awareness of epilepsy and the medical risks associated with it; 
(6) whether the Home Office is being consulted on the action plan to address the finding in the National Audit of Epilepsy-related Death on the adequacy of post-mortem investigations; 
(7) what plans there are for implementation of the action plan addressing the findings of the National Audit of Epilepsy-Related Death; and what funding will be made available for this purpose; 
(8) what plans he has to address the findings of the epilepsy deaths report on the adequacy of post-mortem investigations; 
(9) what measures his Department is taking to improve information and medical training for epilepsy sufferers and carers of people with epilepsy. 
Jacqui Smith: In May 2002, we welcomed the publication of the Government funded national sentinel audit of epilepsy-related death. The audit looked at investigations into epilepsy deaths, care provided prior to death and contact with bereaved families. We have given a commitment to consider in full the recommendations of the audit and to develop an action plan later this year to address the key issues. It will need to take account of and feed into a range of other initiatives including the national service framework for long term conditions (NSF), which will have a focus on neurological conditions such as epilepsy. We expect to meet with the epilepsy voluntary organisations shortly, and will consult with others as appropriate.
19 Sept 2002 : Column 344W
clinicians and organisations to the need to establish or review policies and practices regarding the management of epilepsy and epilepsy related deaths.
Jacqui Smith: In the 2002 budget the Government set a target of recruiting 35,000 nurses, 15,000 doctors and 35,000 scientists and therapists. They will become part of the continuing drive to recruit more health professionals for the National Health Service.
The Department fully supports the need for an increase in the number of neurologists. Recommendations by the medical workforce review team are for the numbers of consultants in neurology to grow by some 50 per cent. by 2010, from 326 in 2001 to 496 in 2010, and some of those consultants may choose to specialise in epilepsy.
There are already about 100 epilepsy specialist nursing posts which have been developed in both hospital and community settings. Primary care trusts will be able to decide about the level of future demand in this area. They are best placed to understand local health needs and commission services to meet them.
19 Sept 2002 : Column 345W
Mr. Hunter: To ask the Secretary of State for Health what assessment he has made of recent research into the measles virus and the spinal fluid of autistic children; if he will commission further research into this issue; and if he will make a statement. 
Ms Blears: All scientists who feel they have some important research findings should publish their work in a peer-review journal and subject it to scrutiny by fellow scientists. The Government are not aware that this study has been published and therefore are unable to make any assessment or commission any further research.
Jacqui Smith: The Medical Research Council (MRC) (which is a non-departmental public body which receives its grant-in-aid from the Department of Trade and Industry via the Office of Science and Technology) is the main public sector body which funds research into autism. The MRC spend on autism since 1997 has been:
I announced on 14 February the allocation of a further £2.5 million to the MRC for autism research. This will complement and add to the MRC's current support for research in this field. The MRC welcomes high quality applications for support in any scientific area which will further our understanding of autism, and especially those areas which were highlighted in their review.
Mr. Wray: To ask the Secretary of State for Health how much money was spent in the NHS on the treatment of autism in the last 12 months for which figures are available; and what plans he has to increase the level of services available. 
Jacqui Smith: National Health Service expenditure on the treatment of autism is not separately identified. Our increased investment in health, education and personal social services in England will benefit people with autism. It is for health authorities, in partnership with primary care trusts and other local stakeholders, to determine how best to use their funds to meet national and local priorities for improving health, tackling health inequalities and modernising services.
Mr. Wray: To ask the Secretary of State for Health what assistance his Department has given to (a) the Scottish Society for Autism and (b) other organisations helping people with autism in the last 12 months for which figures are available. 
Jacqui Smith: Under the Section 64 General Scheme of Grants to Voluntary Organisations, the Department issues funds to further its objectives in the health and social care fields in England. We have not funded the
19 Sept 2002 : Column 346W
Scottish Society for Autism. Three national autistic society projects have received funding in the last 12 months:
|Independence and Autism: Good Practice for Service Providers||£49,000|
|Asperger's Syndrome Project||£40,000|
Ms Blears: We are not aware of any systematic study looking at whether a second dose of MMR has an impact on the rate of autism in children. However, in a recent paper by Farrington et al (2001) (full reference below) they looked at regression in children with autism and found no relationship to either the first or second dose of MMR. This paper was published in a peer review journal.
|Next Section||Index||Home Page|